Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Jordan Gauthier, Emily C. Liang et al.|Transplantation and Cellular Therapy|2023Cited by 144
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell–Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric PatientsAntonio Pérez‐Martínez, Mercedes Gasior Kabat, Raquel de Paz et al.|Transplantation and Cellular Therapy|2018Cited by 56
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcareDaniele Donà, Juan Manuel Torres, Elisa Benetti et al.|Clinical Transplantation|2020Cited by 50
Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)Antonio Pérez‐Martínez, Miguel Ángel Díaz, Cristina Ferreras et al.|American Journal of Hematology|2019Cited by 46
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, Beatriz Ruz-Caracuel, David Bueno et al.|Pediatric Hematology and Oncology|2021Cited by 28